Veeva Systems (VEEV) ended the recent trading session at $193.09, demonstrating a -1.89% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.38%. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq appreciated by 0.9%.
The stock of provider of cloud-based software services for the life sciences industry has risen by 21.36% in the past month, leading the Medical sector's gain of 4.34% and the S&P 500's gain of 1.27%.
Investors will be eagerly watching for the performance of Veeva Systems in its upcoming earnings disclosure. On that day, Veeva Systems is projected to report earnings of $2.22 per share, which would represent year-over-year growth of 11.56%. Alongside, our most recent consensus estimate is anticipating revenue of $904.07 million, indicating a 14.57% upward movement from the same quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $9.05 per share and a revenue of $3.64 billion, indicating changes of +11.73% and +13.96%, respectively, from the former year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Currently, Veeva Systems is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 21.75. This signifies a discount in comparison to the average Forward P/E of 28.61 for its industry.
Also, we should mention that VEEV has a PEG ratio of 0.62. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical Info Systems industry had an average PEG ratio of 3.19 as trading concluded yesterday.
The Medical Info Systems industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 100, positioning it in the top 41% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Veeva Systems Inc. (VEEV): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).